4 more Indian pharma firms expected to produce Covid vaccines by Oct-Nov, Mandaviya says
Union Health Minister Mansukh Mandaviya on Tuesday said in Parliament that four more Indian pharma firms are expected to start anti-coronavirus vaccine production by October-November that will accelerate the inoculation drive.
During the Question Hour in the Rajya Sabha, Mandaviya said India has administered 47 crore doses of vaccine so far and the Centre is making efforts to inoculate the entire country at the earliest.
Even 7 to 9 per cent of the doses that remain unutilised by private hospitals are being used by the government vaccination centres, he added.
Mandaviya was speaking amid a din in the house over the Opposition’s demand for a discussion on the Pegasus issue and the farm laws.
“Vaccination drive is going on smoothly… It will get more accelerated in the coming days with the ramping up of production by four more Indian companies,” the minister said.
The government expects that by October-November, four more Indian pharmaceutical companies will start production of indigenous vaccines that will help meet the domestic demand, he said.
Biologicals E and Novartis vaccines will also be available in the market in the coming days, while Zydus Cadila will soon get an emergency-use nod from an expert committee, the Union Health Minister said
At present, two companies (Bharat Biotech and Serum Institute) are supplying the vaccine to the government. Sputnik vaccine is also available and production of which has begun, he added.